Shedding of syndecan‐1 from human hepatocytes alters very low density lipoprotein clearance
Yiping Deng, Erin M. Foley, Jon C. Gonzales, Philip L. Gordts, Yulin Li, Jeffrey D. Esko – 24 August 2011 – We recently showed that the heparan sulfate proteoglycan syndecan‐1 mediates hepatic clearance of triglyceride‐rich lipoproteins in mice based on systemic deletion of syndecan‐1 and hepatocyte‐specific inactivation of sulfotransferases involved in heparan sulfate biosynthesis. Here, we show that syndecan‐1 expressed on primary human hepatocytes and Hep3B human hepatoma cells can mediate binding and uptake of very low density lipoprotein (VLDL).